Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

12th World Clinical Biomarkers and CDx Summit

Evvnt Promotion / evvnt
-
28.09.2022 - 29.09.2022  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, USA
Time: 6:50 am to 4:35 pm
 
Temi della conferenza
The 12th World Clinical Biomarkers and CDx Summit returns at a crucial time for the entire precision and targeted drug development industry. Spurred on by a number of recent exciting biomarker-driven therapy and CDx approvals by the FDA, including Eli Lilly's Verzenio, J&J's Amivantamab and Takeda's Mobocertinib, the race to market is becoming ever fiercer to deliver the next-generation of safer and more effective therapies for defined patient populations.
Scientific organizer
Hanson Wade
Annotazioni
Speakers: Aaron Schetter, Senior Director, Regulatory Affairs, Companion Diagnostics, Daiichi Sankyo, Inc., Amy Gorman, Director, Global Commercial Strategy, Precision Medicine, Janssen, Antonio Chambers, Associate Director, Technical Diagnostic Test
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1145208-2?pid=4832
Ms. Anita Kelemen
 
Categorie
Laboratorio di Analisi Chimico Clinico, Medicina General
Lingua
Inglese
Quote del Congresso
Free: USD 0.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinAMREF - African Medical and Research FoundationnewTreeÖsterreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioSwiss Tropical and Public Health InstituteAlumni Club Medizinische Universität WienÄrztekammer für Wien